Magnetic Resonance Imaging, Clinical, and Biopsy Findings in Suspected Prostate Cancer: A Systematic Review and Meta-Analysis
A Haj-Mirzaian, KS Burk, R Lacson, DI Glazer… - JAMA Network …, 2024 - jamanetwork.com
Importance Multiple strategies integrating magnetic resonance imaging (MRI) and clinical
data have been proposed to determine the need for a prostate biopsy in men with suspected …
data have been proposed to determine the need for a prostate biopsy in men with suspected …
A Systematic Review of Family History, Race/Ethnicity, and Genetic Risk on Prostate Cancer Detection and Outcomes: Considerations in PSA-based Screening
NJ Graham, LH Souter, SS Salami - Urologic Oncology: Seminars and …, 2024 - Elsevier
Aim To investigate the role of family history, race/ethnicity, and genetics in prostate cancer
(PCa) screening. Methods We conducted a systematic review of articles from January 2013 …
(PCa) screening. Methods We conducted a systematic review of articles from January 2013 …
Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSA
T Benidir, Z Lone, A Wood, N Abdallah, R Campbell… - Urology, 2023 - Elsevier
Abstract Objective To assess how IsoPSA, a structure-based serum assay which has been
prospectively validated in detecting clinically significant prostate cancer (csPCa), can help …
prospectively validated in detecting clinically significant prostate cancer (csPCa), can help …
Accommodating heterogeneous missing data patterns for prostate cancer risk prediction
M Neumair, MW Kattan, SJ Freedland, A Haese… - BMC medical research …, 2022 - Springer
Background We compared six commonly used logistic regression methods for
accommodating missing risk factor data from multiple heterogeneous cohorts, in which some …
accommodating missing risk factor data from multiple heterogeneous cohorts, in which some …
Integrating biomarkers and multi-parametric MRI to provide enhanced clinical diagnosis for prostate cancer
J Alter, DM Albala - Frontiers in Urology, 2023 - frontiersin.org
Prostate cancer (PCa) risk assessment can incorporate clinical features, gene expression,
protein 'biomarkers' or imaging. In this review the benefits of layering multiparametric …
protein 'biomarkers' or imaging. In this review the benefits of layering multiparametric …
Hybrid Approach to Predict Prostate Cancer by IPCA Analysis with Boosting and Bagging Classifier
G Mubarak, C Rajabhushanam - 2023 3rd International …, 2023 - ieeexplore.ieee.org
A malignant cancer that develops in the prostate gland of men is known as prostate cancer.
The small and fuzzy shaped nature of the lesion makes it challenging for the development of …
The small and fuzzy shaped nature of the lesion makes it challenging for the development of …
Maximizing risk prediction by synthesizing multiple data sets accommodating systematic missing data and heterogeneous scales
MJP Neumair - 2022 - mediatum.ub.tum.de
Statistical analyses highly depend on the data quality and sample size. For lots of
hypotheses, it is not sufficient to use only one data source. But data from different sources …
hypotheses, it is not sufficient to use only one data source. But data from different sources …
Globally accessible end-user-friendly prostate cancer risk prediction tools based on contemporary cohorts with heterogeneous missing risk factors
M Neumair, MW Kattan, SJ Freedland, A Haese… - 2022 - researchsquare.com
Background: Missing risk factors, whether random or not measured at all, across different
hospitals and patients provide challenges, both for the developers of online clinical risk tools …
hospitals and patients provide challenges, both for the developers of online clinical risk tools …